These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36427605)

  • 1. Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond.
    Weintraub WS; Mancini GBJ; Boden WE
    Int J Cardiol; 2023 Feb; 373():39-43. PubMed ID: 36427605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application and clinical implications of revascularization on chronic coronary syndromes: From COURAGE to ISCHEMIA trial.
    Tsigkas G; Moulias A; Xaplanteris P; Bousoula E; Tzikas S; Toutouzas K; Davlouros P
    Hellenic J Cardiol; 2021; 62(6):447-451. PubMed ID: 33176210
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical Implications and Debates on the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches Trial.
    Saito Y; Nishi T; Saito K; Kitahara H; Kawase Y; Matsuo H; Kobayashi Y
    Cardiol Rev; 2022 Sep-Oct 01; 30(5):234-240. PubMed ID: 33758121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.
    Mancini GBJ; Hartigan PM; Shaw LJ; Berman DS; Hayes SW; Bates ER; Maron DJ; Teo K; Sedlis SP; Chaitman BR; Weintraub WS; Spertus JA; Kostuk WJ; Dada M; Booth DC; Boden WE
    JACC Cardiovasc Interv; 2014 Feb; 7(2):195-201. PubMed ID: 24440015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Percutaneous coronary intervention versus bypass surgery in patients with diabetes and multivessel coronary disease. Coronary revascularization after FREEDOM].
    Dörr R; Stumpf J; Dalibor J; Simonis G; Spitzer SG
    Herz; 2014 May; 39(3):331-42. PubMed ID: 24740094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).
    Fearon WF; Nishi T; De Bruyne B; Boothroyd DB; Barbato E; Tonino P; Jüni P; Pijls NHJ; Hlatky MA;
    Circulation; 2018 Jan; 137(5):480-487. PubMed ID: 29097450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA.
    Brown DL
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):1039-1045. PubMed ID: 34767134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials.
    Stergiopoulos K; Boden WE; Hartigan P; Möbius-Winkler S; Hambrecht R; Hueb W; Hardison RM; Abbott JD; Brown DL
    JAMA Intern Med; 2014 Feb; 174(2):232-40. PubMed ID: 24296791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
    Fearon WF; Zimmermann FM; Ding VY; Zelis JM; Piroth Z; Davidavicius G; Mansour S; Kharbanda R; Östlund-Papadogeorgos N; Oldroyd KG; Wendler O; Reardon MJ; Woo YJ; Yeung AC; Pijls NHJ; De Bruyne B; Desai M; Hlatky MA;
    Circulation; 2022 May; 145(22):1655-1662. PubMed ID: 35369704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial.
    Kitabata H; Kubo T; Shiono Y; Shimamura K; Ino Y; Tanimoto T; Hayashi Y; Komukai K; Sougawa H; Kimura K; Gohda M; Hashizume T; Obana M; Maeda K; Yamaguchi J; Akasaka T
    Trials; 2019 Jan; 20(1):84. PubMed ID: 30691507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Rationale of the RIPCORD 2 Trial (Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?): A Randomized Controlled Trial to Compare Routine Pressure Wire Assessment With Conventional Angiography in the Management of Patients With Coronary Artery Disease.
    Elguindy M; Stables R; Nicholas Z; Kemp I; Curzen N
    Circ Cardiovasc Qual Outcomes; 2018 Feb; 11(2):e004191. PubMed ID: 29449442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective Comparison of Long-Term Clinical Outcomes Between Percutaneous Coronary Intervention and Medical Therapy in Stable Coronary Artery Disease With Gray Zone Fractional Flow Reserve　- COMFORTABLE Retrospective Study.
    Kubo T; Takahata M; Terada K; Mori K; Arita Y; Ino Y; Matsuo Y; Kitabata H; Shiono Y; Shimamura K; Kameyama T; Emori H; Katayama Y; Tanimoto T; Akasaka T
    Circ J; 2018 Nov; 82(12):3044-3051. PubMed ID: 30318503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.
    Al-Lamee R; Howard JP; Shun-Shin MJ; Thompson D; Dehbi HM; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik IS; Cook C; Ahmad Y; Sharp ASP; Gerber R; Baker C; Kaprielian R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom SA; Davies JE; Francis DP
    Circulation; 2018 Oct; 138(17):1780-1792. PubMed ID: 29789302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease.
    Paul TK; Mamas MA; Shanmugasundaram M; Nagarajarao HS; Ojha CP; Jneid H; Kumar G; White CJ
    Curr Cardiol Rep; 2021 Mar; 23(4):23. PubMed ID: 33655382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.